Autologous Hematopoietic Stem cells (HSCs)

BIOLOGICAL2 trials

Sponsors

University of Florida

Conditions

High Grade GliomaMalignant GliomaProgressive OligodendrogliomaRecurrent Oligodendroglioma

Phase 1

Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas

TerminatedNCT03334305

University of FloridaHigh Grade Glioma, Malignant Glioma

Start: 2018-08-27End: 2025-03-20Updated: 2026-04-23

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients

RecruitingNCT06254326

University of FloridaProgressive Oligodendroglioma, Recurrent Oligodendroglioma

Start: 2024-09-19End: 2028-06-01Target: 12Updated: 2026-05-27

Related Papers

IMMU-27. IMMUNE CHECKPOINT BLOCKADE OF EX VIVO EXPANDED T CELLS FOR USE IN ADOPTIVE CELLULAR THERAPY (ACT) FOR GLIOBLASTOMA

Neuro-Oncology2019-11-01

Abstract 1194: Adoptive cellular therapy overcomes tumor-induced dysregulation of myelopoiesis

Cancer Research2019-07-01

Abstract 1194: Adoptive cellular therapy overcomes tumor-induced dysregulation of myelopoiesis

Tumor Biology2019-07-01

TMIC-29. REPROGRAMMING BONE MARROW OF TUMOR-BEARING HOSTS FOR GLIOMA IMMUNOTHERAPY

Neuro-Oncology2018-11-01